Fly Insider: Yellow Corp, Abbott Labs among week’s notable insider trades

Welcome to “Fly Insider,” The Fly’s weekly recap of notable insider stock transactions.

NOTABLE INSIDER BUYS: Significant insider buys reported in the prior week from July 24 through July 28 include:

•  Beneficial owner of Acumen Pharmaceuticals (ABOS) RA Capital purchased 5,161,290 shares of company stock at $7.75 per share for a total transaction amount of $39,999,998

• Director of Heron Therapeutics (HRTX) Adam Morgan purchased 2,486,744 shares of company stock at $1.37 for a total transaction amount of $3,406,839

• Beneficial owner of Yellow Corp (YELL) MFN Partners purchased 7,105,388 shares of company stock at 61c per share for a total transaction amount of $4,361,287

• Chairman of B Riley Financial (RILY) Bryant Riley purchased 72,727 shares of company stock at $55.00 per share for a total transaction amount of $3,999,985

NOTABLE INSIDER SALES : Significant insider sales reported in the prior week from July 24 through July 28 include:

• VP of Lennar (LEN ) Jeffrey McCall sold 10,000 shares of company stock at $126.48 per share for a total transaction amount of $1,264,800

• Director of Abbott Laboratories (ABT) Daniel Starks sold 50,000 shares of company stock at $113.76 per share for a total transaction amount of $5,688,190

• CFO of NXP Semiconductors (NXPI) Betz William Betz sold 3,514 shares of company stock at $224.38 per share for a total transaction amount of $788,471

• Director of Credo Technology Group Holding (CRDO) Cheng Chi Fung sold 80,000 shares of company stock at $17.15 per share for a total transaction amount of $1,371,880

NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Yellow Corp are up over 130% after beneficial owner MFN Partners purchased 7,105,388 shares of company stock at 61c per share, while shares of Abbott Laboratories are down approximately 2.5% after Director Daniel Starks sold 50,000 shares of company stock at $113.76 per share.